An Open-labeled Phase II Study to Evaluate the Efficacy and Safety of GXNPC-1 in Patients with Chronic Stroke
Clinical trial NCT04088149 · COMPLETED
Trial details
- NCT number
- NCT04088149
- Sponsor
- Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-06
- Primary completion
- 2023-08-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.